ARCHIVES

FDA Approves BMS’s Yervoy For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

Concept Approved For New Quality Assurance Center

May 14, 1982

In Brief: Clearinghouse Charter Renewed For Two Years; Good On China, Carbone On Communciation

May 26, 1978

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

MRI Reveals Information That May Alter Treatment

December 28, 2007